Aurobindo Pharma’s stock witnessed a 3% dip following a fire incident at its Penicillin-G manufacturing facility in Kakinada SEZ, Andhra Pradesh. The fire, which occurred near the coal crusher area, caused damage to ancillary equipment but did not impact the core manufacturing infrastructure. Fortunately, no injuries were reported during the incident.
The company assured investors that the fire would not have a material impact on its operations or financials. A thorough assessment of the damage is underway, and operations at the plant will be temporarily halted for approximately 20 to 25 days to facilitate necessary repairs and equipment replacements.
Aurobindo Pharma emphasized that the facility is fully insured, ensuring that any financial losses from the incident are covered. The company remains focused on resuming full operations while prioritizing safety and quality standards.
While the short-term impact includes a temporary shutdown of the plant, Aurobindo Pharma’s management is confident that the facility will return to normalcy soon, minimizing long-term disruptions.
Aurobindo Pharma’s stock opened at ₹1,238.40 today, reaching a high of ₹1,244.10 and a low of ₹1,206.10. The 52-week high for the stock stands at ₹1,592.00, while the 52-week low is ₹1,010.00.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
